CRA International
CRAI
174.60
-0.34
-0.19%
CRA International
US · CRAI
#3183 by market cap
174.60
-0.34
-0.19%
Live - 5344 symbols - heartbeat 17s ago
· 2026-10-08 10:10
Pre-market
174.94
0.00%
After-hours
174.60
-0.19%
- Market cap
- 1.10B
- P/E (TTM)i
- 23.25
- P/Bi
- 6.03
- EPSi
- 8.14
- Div yieldi
- 1.26%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on CRAI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.66, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.33% YoY
Margins
- Gross margin
- 30.91%
- Operating margin
- 11.06%
- Net margin
- 7.28%
Key ratios & quality
- PEG ratioi
- 2.95
- Altman Z-Scorei
- 3.66
PEG uses trailing P/E against the 3-year net income growth rate (7.89%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 417.65M | 451.37M | 508.37M | 565.93M | 590.90M | 623.98M | 687.41M | 751.58M |
| Gross profit | 128.46M | 133.61M | 137.66M | 165.88M | 180.82M | 184.23M | 207.48M | 232.30M |
| Selling & admin expenses | 89.53M | 93.61M | 90.03M | 97.37M | 110.09M | 115.12M | 125.05M | 135.03M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 28.94M | 29.35M | 34.80M | 55.74M | 58.74M | 57.55M | 70.75M | 83.12M |
| Pretax profit | 28.93M | 26.80M | 33.62M | 54.28M | 58.80M | 52.29M | 66.24M | 76.57M |
| Tax | 6.46M | 6.05M | 9.12M | 12.60M | 15.18M | 13.81M | 19.59M | 21.79M |
| Net profit | 22.47M | 20.75M | 24.51M | 41.68M | 43.62M | 38.48M | 46.65M | 54.78M |
| Basic EPS | 3 | 3 | 3 | 6 | 6 | 5 | 7 | 8 |
| Diluted EPS | 2.61 | 2.53 | 3.07 | 5.45 | 5.91 | 5.39 | 6.74 | 8.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 181.85M | 186.88M | 185.89M | 196.96M | 200.98M | 210.82M |
| Gross profit | 61.50M | 58.34M | 54.42M | 58.04M | 55.95M | 62.08M |
| Selling & admin expenses | 32.54M | 35.08M | 33.73M | 33.69M | 34.52M | 35.26M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 25.55M | 19.73M | 17.21M | 20.64M | 18.03M | 23.54M |
| Pretax profit | 24.65M | 17.12M | 16.22M | 18.59M | 17.40M | 20.12M |
| Tax | 6.64M | 4.99M | 4.75M | 5.40M | 6.27M | 6.61M |
| Net profit | 18.00M | 12.12M | 11.47M | 13.19M | 11.13M | 13.51M |
| Basic EPS | 3 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 2.62 | 1.79 | 1.73 | 1.99 | 1.69 | 2.10 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 181.14M | 184.08M | 219.97M | 249.35M | 248.86M | 265.48M | 269.36M | 303.13M |
| Cash & ST investments | 38.03M | 25.64M | 45.68M | 66.13M | 31.45M | 45.59M | 26.71M | 18.21M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 370.85M | 533.24M | 558.51M | 555.36M | 550.92M | 553.21M | 571.44M | 628.87M |
| Total current liabilities | 142.50M | 171.41M | 200.13M | 213.09M | 217.13M | 236.09M | 251.31M | 330.03M |
| Short-term debt | -- | 12.85M | 13.56M | 14.34M | 15.97M | 16.48M | 18.70M | 51.22M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 174,374,000.00 | 335,492,000.00 | 349,491,000.00 | 349,526,000.00 | 339,763,000.00 | 341,110,000.00 | 359,366,000.00 | 415,275,000.00 |
| Total equity | 196.47M | 197.75M | 209.02M | 205.83M | 211.15M | 212.10M | 212.07M | 213.60M |
| Retained earnings | 186.23M | 200.25M | 217.00M | 215.78M | 224.39M | 224.28M | 225.46M | 221.06M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 278.12M | 293.11M | 305.58M | 303.13M | 316.47M | 338.98M |
| Cash & ST investments | 25.60M | 19.45M | 22.50M | 18.21M | 32.50M | 21.44M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 590.44M | 606.78M | 629.04M | 628.87M | 662.41M | 678.48M |
| Total current liabilities | 270.50M | 317.33M | 338.60M | 330.03M | 380.84M | 415.21M |
| Short-term debt | 103.99M | 138.72M | 113.67M | 51.22M | 209.24M | 236.70M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 363,123,000.00 | 409,777,000.00 | 427,386,000.00 | 415,275,000.00 | 464,024,000.00 | 496,629,000.00 |
| Total equity | 227.32M | 197.00M | 201.66M | 213.60M | 198.39M | 181.85M |
| Retained earnings | 240.03M | 206.49M | 211.66M | 221.06M | 209.19M | 192.24M |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 36.19M | 27.83M | 54.66M | 75.70M | 25.12M | 60.07M | 49.74M | 22.42M |
| Depreciation & amortization | 10.00M | 21.31M | 24.88M | 25.78M | 25.75M | 25.84M | 26.82M | 29.51M |
| Free cash flow | 20.74M | 11.14M | 37.57M | 73.08M | 21.31M | 57.71M | 33.11M | 18.56M |
| Dividends paid | -6.04M | -6.79M | -7.50M | -8.29M | -9.58M | -10.81M | -12.30M | -13.83M |
| Stock buybacks / issuance | -27.88M | -18.07M | -13.37M | -44.98M | -27.63M | -31.42M | -33.35M | -47.15M |
| Ending cash balance | 38.03M | 25.64M | 45.68M | 66.13M | 31.45M | 45.59M | 26.71M | 18.21M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -79.99M | 5.85M | 36.55M | 60.02M | -113.89M | -4.42M |
| Depreciation & amortization | 7.26M | 7.43M | 7.38M | 7.44M | 7.10M | 6.99M |
| Free cash flow | -80.97M | 4.66M | 35.90M | 58.96M | -116.54M | -6.07M |
| Dividends paid | -3.49M | -3.37M | -3.24M | -3.73M | -3.81M | -3.63M |
| Stock buybacks / issuance | 0 | -43.15M | -4.00M | 0 | -21.46M | -27.84M |
| Ending cash balance | 25.60M | 19.45M | 22.50M | 18.21M | 32.50M | 21.44M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.10 | 10.50 | 12.00 | 20.01 | 20.84 | 18.12 | 21.94 | 25.69 |
| ROA %i | 6.11 | 4.58 | 4.47 | 7.45 | 7.86 | 6.95 | 8.27 | 9.11 |
| ROIC %i | 11.35 | 6.08 | 7.04 | 11.96 | 13.22 | 12.58 | 15.60 | 17.84 |
| 5-year avg ROE %i | 6.13 | 6.99 | 8.67 | 11.45 | 14.89 | 16.29 | 18.58 | 21.32 |
| EBIT margin %i | 7.08 | 6.21 | 6.85 | 9.76 | 10.26 | 8.99 | 10.28 | 10.90 |
| FCF / sales %i | 4.97 | 2.47 | 7.39 | 12.91 | 3.61 | 9.25 | 4.82 | 2.47 |
| Current ratioi | 1.27 | 1.07 | 1.10 | 1.17 | 1.15 | 1.12 | 1.07 | 0.92 |
| Quick ratioi | 1.23 | 1.03 | 1.06 | 1.12 | 1.09 | 1.08 | 1.01 | 0.86 |
| Debt / assetsi | 0.00 | 29.89 | 27.40 | 24.99 | 22.14 | 19.66 | 18.07 | 20.23 |
| LT debt / equityi | -- | 74.11 | 66.72 | 60.47 | 50.20 | 43.51 | 39.86 | 35.59 |
| Interest coveragei | 45.72 | 22.37 | 28.65 | 56.95 | 33.20 | 14.72 | 16.00 | 15.29 |
| Revenue CAGR (3Y) %i | 11.22 | 11.60 | 11.16 | 10.66 | 9.39 | 7.07 | 6.70 | 8.35 |
| Net income CAGR (3Y) %i | 43.22 | 17.20 | 47.58 | 22.83 | 28.11 | 16.23 | 3.83 | 7.89 |
| FCF CAGR (3Y) %i | 103.84 | -31.82 | 1.34 | 52.16 | 24.14 | 15.38 | -23.19 | -4.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 23.15 | 29.03 | 27.81 | 25.69 | 22.46 | 25.98 |
| ROA %i | 8.90 | 9.79 | 9.32 | 9.11 | 7.63 | 7.66 |
| ROIC %i | 13.49 | 14.92 | 15.62 | 17.84 | 11.66 | 11.93 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.93 | 11.79 | 11.57 | 10.90 | 9.77 | 10.00 |
| FCF / sales %i | 2.29 | 2.96 | 3.89 | 2.47 | -- | -- |
| Current ratioi | 1.03 | 0.92 | 0.90 | 0.92 | 0.83 | 0.82 |
| Quick ratioi | 0.96 | 0.86 | 0.85 | 0.86 | 0.77 | 0.76 |
| Debt / assetsi | 31.32 | 36.90 | 30.89 | 20.23 | 42.29 | 44.75 |
| LT debt / equityi | 35.61 | 43.23 | 40.00 | 35.59 | 35.73 | 36.82 |
| Interest coveragei | 17.40 | 17.91 | 16.96 | 15.29 | 12.67 | 11.19 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Professional and consulting services100.00%
Quote time 2026-10-08 10:10:35 · For reference only, not investment advice and not tailored to your situation.